Skip to main content
. 2023 Dec 1;23:1182. doi: 10.1186/s12885-023-11692-7

Table 3.

NRI and IDI of the nomogram and the TNM stage in survival prediction for SCLC patients in the training and validation sets

Index Training set Validation set
Estimate 95%CI p Estimate 95%CI p
NRI (vs. the TNM stage)
 1-year OS 0.255 0.189–0.308 < 0.001 0.154 0.034–0.257 0.012
 3-year OS 0.210 0.143–0.274 < 0.001 0.157 -0.030-0.271 0.096
 5-year OS 0.198 0.106–0.274 < 0.001 -0.040 -0.226-0.106 0.363
IDI (vs. the TNM stage)
 1-year OS 0.056 0.040–0.080 < 0.001 0.040 0.014–0.065 0.004
 3-year OS 0.047 0.032–0.071 < 0.001 0.025 -0.010-0.052 0.112
 5-year OS 0.041 0.024–0.067 < 0.001 -0.006 -0.064-0.031 0.715

Note: NRI, Net Reclassification Improvement; IDI, Integrated Discrimination Improvement; OS, overall survival